Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSR | P00390 | 1/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 5/20 | 0.33 |
| ▸ | CPB1 | P15086 | 2/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MC4R | P32245 | 3/20 | 0.31 |
| ▸ | MC5R | P33032 | 2/20 | 0.31 |
| ▸ | MC3R | P41968 | 2/20 | 0.31 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.31 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.31 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.30 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6256586 | 0.84 | GSR (0.34) | GSRCPB2CPB1ITGB3ITGA2B | |
| SCHEMBL259180 | 0.84 | — | — | |
| SCHEMBL5884482 | 0.84 | GSR (0.38) | GSRCPB2CPB1MMP2MC4R | |
| D-Histidine SCHEMBL902054 | 0.83 | GSR (0.54) | GSRCPB2CPB1MMP2ITGB3 | |
| Histidine SCHEMBL4294462 | 0.83 | GSR (0.54) | GSRCPB2CPB1MMP2ITGB3 | |
| Histidine SCHEMBL305856 | 0.83 | GSR (0.54) | GSRCPB2CPB1MMP2ITGB3 | |
| Histidine SCHEMBL16714200 | 0.83 | GSR (0.54) | GSRCPB2CPB1MMP2ITGB3 | |
| Histidine SCHEMBL18419548 | 0.83 | GSR (0.54) | GSRCPB2CPB1MMP2ITGB3 | |
| Histidine SCHEMBL305855 | 0.83 | GSR (0.54) | GSRCPB2CPB1MMP2ITGB3 | |
| Histidine SCHEMBL4297918 | 0.83 | GSR (0.54) | GSRCPB2CPB1MMP2ITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9586989-B1 | Non-toxic skin cancer therapy with copper peptides | SKIN BIOLOGY, INC. (US) | 2017-03-07 | — | — | US | disclosed |
| EP-0514460-A1 | ANTI-OXIDATIVE AND ANTI-INFLAMMATORY METAL:PEPTIDE COMPLEXES AND USES THEREOF | PROCYTE CORPORATION (US) | 1992-11-25 | — | — | EP | disclosed |
| WO-1991012267-A1 | ANTI-OXIDATIVE AND ANTI-INFLAMMATORY METAL:PEPTIDE COMPLEXES AND USES THEREOF | PROCYTE CORPORATION (US) | 1991-08-22 | — | — | WO | disclosed |